Clinical Trial Update: Lifetech LAmbre™ Left Atrial Appendage (LAA) Closure System Post-Market Clinical Follow-up Study

View source ↗

Summary

A post-market clinical follow-up study of Lifetech's LAmbre Left Atrial Appendage Closure System for atrial fibrillation has completed. The study status is repo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• LAmbre Left Atrial Appendage Closure System (left atrial appendage closure device)

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Atrial Fibrillation | Status: COMPLETED